These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38311637)

  • 21. Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer.
    Lin H; Cao B
    Dis Markers; 2022; 2022():3592990. PubMed ID: 35937946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
    Lv J; Zhu Y; Ji A; Zhang Q; Liao G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32239176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
    Yang M; He H; Peng T; Lu Y; Yu J
    Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes.
    Jiang HZ; Yang B; Jiang YL; Liu X; Chen DL; Long FX; Yang Z; Tang DX
    Front Oncol; 2022; 12():1025397. PubMed ID: 36387195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer.
    Zhang HC; Deng SH; Pi YN; Guo JN; Xi H; Shi X; Yang XF; Zhang BM; Xue WN; Cui BB; Liu YL
    Front Immunol; 2022; 13():855849. PubMed ID: 35444656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 28. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
    Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
    Front Immunol; 2022; 13():984149. PubMed ID: 36300121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis.
    Fang Z; Xu S; Xie Y; Yan W
    World J Surg Oncol; 2021 Jan; 19(1):13. PubMed ID: 33441161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
    Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
    J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Characterization of RNA-Binding Proteins in Colon Adenocarcinoma Identifies a Novel Prognostic Signature for Predicting Clinical Outcomes and Immunotherapy Responses Based on Machine Learning.
    Miao Y; Yuan Q; Wang C; Feng X; Ren J; Wang C
    Comb Chem High Throughput Screen; 2023; 26(1):163-182. PubMed ID: 35379120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.
    Yan D; Chen Y
    Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APC mutation correlated with poor response of immunotherapy in colon cancer.
    Li B; Zhang G; Xu X
    BMC Gastroenterol; 2023 Mar; 23(1):95. PubMed ID: 36977982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method.
    Li Z; Jiang L; Zhao R; Huang J; Yang W; Wen Z; Zhang B; Du G
    Medicine (Baltimore); 2021 May; 100(21):e26068. PubMed ID: 34032736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
    Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
    Front Genet; 2021; 12():623424. PubMed ID: 33664769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer.
    Zeng C; He R; Dai Y; Lu X; Deng L; Zhu Q; Liu Y; Liu Q; Lu W; Wang Y; Jin J
    Front Pharmacol; 2022; 13():1069204. PubMed ID: 36467074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.